Price Alert

CNS Pharmaceuticals Inc. (CNSP)

NASDAQ: CNSP · Real-Time Price · USD

4.96

-1.07 (-17.74%)

At close: Aug 15, 2025, 3:59 PM

5.31

7.06%

After-hours: Aug 15, 2025, 07:59 PM EDT

CNS Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	13.05M	6.46M	6.97M	1.49M	815.23K	548.72K	909.55K	4.28M	5.11M	10.06M	7.03M	8.96M	12.44M	5M	8.33M	6.89M	11.08M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	22.38K	36.43K	18.37K	320.32K	55.3K	307.61K	262.73K	377.2K	438.13K	482.81K	929.04K	1.04M	1.13M	1.26M	334.14K	334.14K	334.14K
Receivables	n/a	882.54K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.7M	132.65K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	674.43K	1.31M	414.97K	653.84K	786.05K	202.86K	1.15M	1.79M	1.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	13.72M	8.66M	7.39M	2.15M	1.6M	1.59M	2.06M	6.07M	6.97M	12.56M	8.7M	11.4M	14.73M	7.48M	11.16M	13.88M	12.79M
Property-Plant & Equipment	4.91K	6K	2.8K	3.55K	4.3K	4.93K	3.47K	3.38K	4.38K	5.66K	8.52K	10.97K	12.73K	16.11K	17.53K	20.89K	24.11K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	27.29K	42.44K	21.18K	323.87K	59.6K	312.54K	266.2K	380.58K	442.52K	488.47K	937.56K	1.05M	1.14M	1.28M	351.66K	355.03K	358.24K
Total Assets	13.75M	8.7M	7.41M	2.47M	1.66M	1.7M	2.33M	6.45M	7.41M	13.05M	9.64M	12.45M	15.87M	8.76M	11.51M	14.24M	13.14M
Account Payables	2.57M	2.2M	4.03M	6.64M	5.88M	5.83M	4.03M	3.57M	2.78M	3.68M	1.01M	490.89K	489.72K	1.52M	1.46M	892.49K	1.06M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	210.67K	326.07K	31.19K	123.25K	213.1K	300.81K	41.9K	166.4K	289.07K	409.97K	39.26K	156.4K	272.57K	387.79K	44.63K	177.58K	309.13K
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.78M	2.52M	4.06M	6.76M	6.09M	6.13M	4.07M	4M	3.92M	4.92M	1.24M	923.86K	1.07M	2.14M	2.41M	1.83M	1.9M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	2.78M	2.52M	4.06M	6.76M	6.09M	6.13M	4.07M	4M	3.92M	4.92M	1.24M	923.86K	1.07M	2.14M	2.41M	1.83M	1.9M
Total Debt	210.67K	326.07K	31.19K	123.25K	213.1K	300.81K	41.9K	166.4K	289.07K	409.97K	39.26K	156.4K	272.57K	387.79K	44.63K	177.58K	309.13K
Common Stock	2.94K	1.41K	33.45K	1.44K	10.67K	6.21K	4.21K	4.14K	2.23K	1.62K	40.03K	40.03K	40.03K	27.93K	27.46K	27.38K	25.35K
Retained Earnings	-88.73M	-84.42M	-81.25M	-75.64M	-73.11M	-69.57M	-64.19M	-59.67M	-55.65M	-50.72M	-44.75M	-41.33M	-37.77M	-34.98M	-32.19M	-28.37M	-24.56M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	10.97M	6.18M	3.35M	-4.29M	-4.43M	-4.43M	-1.74M	2.45M	3.49M	8.13M	8.39M	11.52M	14.8M	6.62M	9.1M	12.41M	11.24M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a